Valuation: Acotec Scientific Holdings Limited

Market Cap 1.56B 1.83B 233M 208M 192M 174M 328M 22.09B 333M 2.31B 907M 11.56B 875M 857M 36.88B P/E 2026 *
11.6x
P/E 2027 * 9.2x
Enterprise Value 1.56B 1.83B 233M 208M 192M 174M 328M 22.09B 333M 2.31B 907M 11.56B 875M 857M 36.88B EV / Sales 2026 *
2.14x
EV / Sales 2027 * 1.71x
Free-Float
16.41%
Yield 2026 *
-
Yield 2027 * -
1 day-1.54%
1 week-0.52%
Current month-8.87%
1 month-6.66%
3 months-29.71%
6 months-50.35%
Current year-57.41%
1 week 5.69
Extreme 5.69
5.98
1 month 5.69
Extreme 5.69
6.32
Current year 5.5
Extreme 5.5
15.32
1 year 5.5
Extreme 5.5
15.32
3 years 5.26
Extreme 5.26
15.47
5 years 4.21
Extreme 4.21
19.88
10 years 4.21
Extreme 4.21
19.88
Manager TitleAgeSince
Chief Executive Officer 54 2021-01-28
Chief Tech/Sci/R&D Officer 48 2021-01-28
Chief Tech/Sci/R&D Officer 85 2021-01-28
Director TitleAgeSince
Chairman 54 2021-01-28
Director/Board Member 56 2020-12-02
Director/Board Member 79 2021-01-28
Date Insider Type Main position Quantity % Market Cap. Importance
7/13/26 Other

Chief Executive Officer

-628,316 0.2005%
6/8/23 Other

Chief Executive Officer

7,208,000 2.3000%
9/24/21 Other

Chief Executive Officer

342,000 0.1091%
Change 5-day change 1-year change 3-year change Capi.($)
-1.54%-0.52%-55.77%-52.08% 232M
-1.55%-0.16%-20.89%+5.86% 180B
+2.17%+7.73%-20.15%+14.57% 114B
+2.00%+1.74%-1.34%+30.17% 114B
-1.02%+2.87%-52.05%-7.70% 78.39B
+0.96%+3.99%+4.85%+81.86% 64.88B
+2.35%+4.76%+16.10%+83.52% 54.02B
+1.60%+3.43%+1.47%-25.07% 51.96B
+0.38%+7.23%-13.29%+30.66% 43.79B
-0.28%+0.80%+25.30%-0.27% 32.45B
Average +0.51%+2.75%-11.58%+16.15% 73.36B
Weighted average by Cap. +0.54%+3.01%-12.01%+20.97%

Financials

2026 *2027 *
Net sales 728M 855M 109M 97.01M 89.91M 81.47M 153M 10.32B 156M 1.08B 424M 5.4B 409M 400M 17.24B 910M 1.07B 136M 121M 112M 102M 191M 12.91B 195M 1.35B 530M 6.75B 511M 500M 21.55B
Net income 128M 150M 19.16M 17.06M 15.81M 14.32M 26.92M 1.82B 27.37M 190M 74.51M 950M 71.88M 70.39M 3.03B 164M 193M 24.55M 21.85M 20.25M 18.35M 34.49M 2.33B 35.07M 243M 95.47M 1.22B 92.09M 90.18M 3.88B
Net Debt - -
Projected Income Statement - Annual - Acotec Scientific Holdings Limited
Logo Acotec Scientific Holdings Limited
Acotec Scientific Holdings Ltd is a company engaged in interventional medical device business. The Company is primarily engaged in the research and development on providing treatment solutions for vascular diseases, involving drug-coated balloons (DCB) and percutaneous transluminal angioplasty balloon catheters (PTA). The Company’s main products include AcoArt Orchid & Dhalia, AcoArt Tulip & Litos, AcoArt Iris & Jasmin, AcoArt Lily & Rosmarin, Peripheral Aspiration System (AcoStream), Radiofrequency Ablation System (AcoArt Cedar), 2nd Gen Peripheral Aspiration System (2nd Generation AcoStream) and others, covering fields such as vascular surgery, cardiology, nephrology and neurology. The Company conducts its businesses within domestic and overseas markets.
Employees
955
Date Price Change Volume
26-10-20 HK$5.750 -1.54% 319,754
26-10-20 HK$5.840 +0.34% 541,511
26-10-16 HK$5.820 -0.43% 614,000
26-10-15 HK$5.845 +1.12% 478,000
26-10-14 HK$5.780 -1.87% 580,000
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Acotec Scientific Holdings Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.970CNY
Average target price
15.00CNY
Spread / Average Target
+201.73%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Acotec Scientific Holdings Limited
  1. Stock Market
  2. Stocks
  3. 6669 Stock